December 17, 2020 08:03 AM Eastern Standard Time – BERKELEY, Calif. & SEOUL–(BUSINESS WIRE)–Lygos, Inc., a vertically integrated provider of safe and sustainable specialty ingredients, and Metalabs...
Cannabinoids
European synthetic biology company Octarine raises $1.8M USD in funding and enters pre-clinical studies with novel-improved- cannabinoid and psychedelic derivatives
COPENHAGEN, DENMARK (PRWEB) NOVEMBER 12, 2020 Today, Octarine Bio ApS (“Octarine” or the “Company”), a synthetic biology company developing biosynthetic platforms for cannabinoids, psychedelics and their novel improved...
